Stock Analysis

Trajan Group (ASX:TRJ) continues working through a business reset aimed at improving profitability and strengthening its position in the analytical science sector. The Victorian-based company supplies scientific instruments, consumables and related technologies used across healthcare, environmental and industrial applications.

Metro Mining (ASX:MMI) continues to advance its position as an Australian bauxite producer, with operational performance at the Bauxite Hills mine remaining central to its growth strategy. The company has been focused on increasing shipment volumes, improving operational reliability and capturing opportunities from ongoing …

Proteomics International (ASX:PIQ) continues to progress its precision diagnostics strategy as the company moves from clinical validation towards commercialisation of its Promarker blood-test platform. The Perth-based healthcare technology company is focused on converting its diagnostic capabilities into scalable healthcare solutions through partnerships, regulatory advancement …

Xenora Minerals (ASX:XRA) remains an early-stage resources explorer focused on building exposure to the critical minerals sector. The company represents the higher-risk segment of the resources market, where long-term value is generally driven by exploration success, project identification and the ability to advance mineral …

Viva Energy (ASX:VEA) continues to evolve as one of Australia’s major integrated energy and convenience retail businesses, combining refining, fuel distribution and consumer-facing operations. The company’s recent performance has highlighted the benefits of stronger refining conditions while also reinforcing the importance of building more …

PYC Therapeutics (ASX:PYC) remains focused on advancing its genetic medicine pipeline as the company works towards developing RNA-based therapies for rare diseases. The Perth-based biotechnology company is centred on translating its proprietary delivery technology into potential treatments for conditions with significant unmet medical needs.

Korvest (ASX:KOV) continues to strengthen its position as an Australian industrial products and engineering company, supported by infrastructure demand, manufacturingInvestmentand a diversified operating model. The company’s latest financial performance highlighted a combination of record revenue growth and ongoing investment aimed at supporting future expansion.